Veterinary Drug Residues & MRLs
| Publication Date | January 2006 |
|---|---|
| Publisher | Animal Pharm |
| Product Type | Report |
| Pages | 186 |
| ISBN Number | not applicable |
| Product Code | ANP00016 |
Summary
The monitoring and controlling of veterinary residues in animal food products is a result of the heightened awareness of consumers. They require objective information that what they put on their plates is safe. This phenomenon has fuelled the need for quality assurance upon which international food trade is dependent. A recent survey commissioned by the European Union (EU) found that food safety is a major concern of European consumers. More than 60 per cent of the 23,000 people taking part indicated that they were "very concerned about the safety of food" when it came to chemical contaminants, which include veterinary drugs.
This report provides an overview of how regulatory bodies around the world control and monitor veterinary drug residues in samples taken from foodproducing animals. They include countries in Europe, North and South America, Asia and Australasia. The international framework - as established by the Codex Alimentarius (Codex) under the aegis of the World Health Organization (WHO) and the Food and Agriculture Organization (FAO) - for controlling residues is also discussed, as are detection techniques.
Country chapters include information on the laws in place to ensure that residues are kept in check, with details of maximum residue limits (MRLs) in force and data tables, where the most recent results of sample testing are summarised. The countries covered in this report are:
- Argentina;
- Australia;
- Austria;
- Brazil;
- Canada;
- China;
- Germany;
- India;
- Ireland;
- Japan;
- Mexico;
- New Zealand;
- Switzerland;
- Thailand;
- United Kingdom;
- United States; and
- The EU.
The most commonly featured commodity is meat, specifically from cattle, pig, chicken and sheep; also summarised to a certain degree are data on eggs, milk and aquaculture products. As far as supranational bodies are concerned, the report contains a detailed chapter on the EU and its 25 member states. The bloc plays an important role in determining food safety worldwide, given the substantial food imports it receives from outside its borders.
It was not possible to include data for all the countries covered in this report as some chose not to make such information available to the author. That is not to say that these countries do not monitor residues at all. Some of them do conduct stringent monitoring for the purpose of exporting to markets, which employ high standards when it comes to food quality, such as in Europe. However, this data is not normally for public consumption and there appears to be a reluctance to release them to other parties.
Two chapters are devoted to the major causes of residues and detection techniques. The former considers the "usual suspects", i.e. substances, which are either banned in the treatment of food-producing animals and/or those whose residual presence are required by law to be within strictly defined limits. It also outlines husbandry practices, which result in residues.
The section on detection discusses testing techniques, which are widely used in this arena, such as rapid immunological tests, liquid chromatography and mass spectrometry, to name a few. Also considered are novelties on the scene, such as biosensors, surface plasmon resonance and the use of alternative matrices.
Finally, horizon issues are discussed in the report's final chapter. This covers future challenges, which include the harmonisation of standards in testing and setting of MRLs, as well as technical issues, which need to be resolved to ensure the better detection and management of drug residues.
Content
- CHAPTER 1 MAJOR CAUSES
- 1.1 Introduction
- 1.2 Withdrawal periods
- 1.3 Hygiene
- 1.4 Misuse
- 1.5 Veterinarian
- 1.6 Risky residues
- 1.6.1 Hormonal growth promoters
- 1.6.2 Beta-agonists
- 1.6.3 Bovine somatotrophin
- 1.6.4 Penicillins
- 1.6.5 Cephalosporins
- 1.7 Selected macrolide antibiotics
- 1.7.1 Spiramycin
- 1.7.2 Tilmicosin
- 1.8 Aminoglycosides
- 1.8.1 Adverse effects
- 1.9 Fluoroquinolones
- 1.10 Sulfadimidine (sulfamethazine)
- 1.11 Nitrofurans and nitroimidazoles
- 1.12 Chloramphenicol
- 1.13 Ivermectin
- 1.14 Tranquilisers
- 1.14.1 Xylazine
- 1.14.2 Azaperone
- 1.15 Carazolol
- CHAPTER 2 DETECTION AND TECHNOLOGY
- 2.1 Introduction
- 2.2 Ante- and post-mortem inspection
- 2.3 Screening methods
- 2.3.1 Rapid tests
- 2.3.2 Microbiological inhibition tests
- 2.3.3 Electrophoretic systems
- 2.3.4 Investigating further with ELISA and RIA
- 2.3.5 Receptor tests
- 2.3.6 Confirming results
- 2.3.7 Chromatography and spectrometry
- 2.3.8 Validation
- 2.3.9 Identification points
- 2.3.10 Analytical methods in the EU
- 2.4 Emerging technologies
- 2.4.1 Introduction
- 2.4.2 Variations on a theme
- 2.4.2.1 Old with the new
- 2.4.3 Biosensors
- 2.4.3.1 Surface plasmon resonance
- 2.4.3.2 Electrochemical biosensors
- 2.4.3.3 BioCop
- CHAPTER 3 CONTROLS AND PREVENTION
- 3.1 Introduction
- 3.2 Registration and distribution
- 3.3 Veterinarian responsibilities
- 3.4 Farmer/producer responsibilities
- 3.4.1 Hygiene
- 3.4.2 Feed
- 3.4.3 Monitoring
- 3.4.4 Record keeping
- 3.5 Scrutiny
- CHAPTER 4 INTERNATIONAL FOOD SAFETY AND THE CODEX ALIMENTARIUS
- 4.1 Introduction
- 4.2 Setting standards
- 4.3 Establishing ADIs
- 4.3.1 Veterinary hypothetical diet
- 4.4 Disadvantages
- CHAPTER 5 THE EUROPEAN UNION
- 5.1 Legislation and Regulation
- 5.2 Setting MRLs
- 5.3 National monitoring
- 5.3.1 Sampling
- 5.3.2 Infringements
- 5.3.3 Residue categories
- 5.4 Third countries
- 5.4.1 Monitoring
- 5.4.2 Inspections
- 5.5 Residue incidence rates
- 5.5.1 Latest results
- 5.5.2 Non-compliant results
- 5.5.2.1 Hormones
- 5.5.2.2 Corticosteroids
- 5.5.2.3 Beta-agonists
- 5.5.2.4 Prohibited substances
- 5.5.2.5 Antibacterials
- 5.5.2.6 Anthelmintics
- 5.6 Incidence rate tables
- 5.6.1 Country codes
- 5.6.2 Bovines: non-compliant results
- 5.6.3 Pigs: non-compliant results
- 5.6.4 Poultry: non-compliant results
- 5.6.5 Sheep and goats: non-compliant results
- CHAPTER 6 UNITED KINGDOM
- 6.1 Legislation and Regulation
- 6.2 Statutory surveillance
- 6.3 Non-statutory surveillance
- 6.4 Surveillance results 2005
- 6.4.1 Statutory results
- 6.4.1.1 Emamectin and malachite green in fish
- 6.4.1.2 Coccidiostats
- 6.4.1.3 Phenylbutazone in cattle and horse
- 6.4.1.4 Nitrofuran and Nortestosterone
- 6.4.2 Non-statutory results
- 6.4.2.1 Farmed fish and crustaceans
- 6.4.2.2 Retailer results
- CHAPTER 7 IRELAND
- 7.1 Legislation and Regulation
- 7.2 Results 2005
- 7.2.1 Banned substances
- 7.2.2 Antibiotics
- 7.2.3 Anticoccidials
- 7.2.4 Aquaculture
- 7.2.5 Follow-up actions
- CHAPTER 8 GERMANY
- 8.1 Legislation and Regulation
- 8.2 Non-compliant results
- 8.3 Results 2004
- 8.4 Results by substance group
- 8.4.1 Anabolic and unauthorised substances
- 8.4.2 Antibacterials
- CHAPTER 9 SWITZERLAND
- 9.1 Legislation and regulation
- 9.1.1 Testing
- 9.1.1.1 Sample collection
- 9.2 Results
- 9.3 Infringement
- CHAPTER 10 AUSTRIA
- 10.1 Legislation and regulation
- 10.2 Results 2005
- CHAPTER 11 AUSTRALIA
- 11.1 Legislation and Regulation
- 11.2 Sampling
- 11.3 Tracing back
- 11.4 Results
- 11.4.1 Anthelmintics
- 11.4.2 Antibacterials
- 11.4.3 Hormones
- 11.4.4 Steroids
- 11.5 Incidence rates
- CHAPTER 12 NEW ZEALAND
- 12.1 Legislation and regulation
- 12.1.1 Risk management
- 12.2 Results
- CHAPTER 13 JAPAN
- 13.1 Legislation and regulation
- 13.1.1 Establishing MRLs
- 13.1.2 Imports
- 13.2 Incidence rates
- 13.2.1 Imported food results 2003-4
- 13.2.2 Imported food results 2004-5
- 13.2.3 Latest imported food data
- 13.2.4 Domestic food results 2003-4
- 13.2.5 Domestic food results 2004-5
- CHAPTER 14 CHINA
- 14.1 Legislation and regulation
- 14.1.1 Non-compliant results
- 14.2 MRLs
- 14.3 EU relations
- 14.3.1 Chinese exports to EU
- 14.3.2 On-site inspections
- 14.3.2.1 Background
- 14.3.2.2 NRMP 2006
- CHAPTER 15 HONG KONG
- 15.1 Legislation and Regulation
- 15.1.1 Inspections
- 15.2 Non-compliance consequences
- 15.3 Results
- CHAPTER 16 THAILAND
- 16.1 Legislation and Regulation
- 16.2 Setting MRLs
- 16.3 Results
- CHAPTER 17 INDIA
- 17.1 Legislation and Regulation
- 17.2 Exports and MRLs
- 17.3 EU certification
- CHAPTER 18 ARGENTINA
- 18.1 Legislation and Regulation
- 18.2 Results
- CHAPTER 19 MEXICO
- 19.1 Legislation and Regulation
- 19.2 MRLs
- 19.3 Results
- 19.4 EU relations
- CHAPTER 20 BRAZIL
- 20.1 Legislation and Regulation
- 20.1.1 Banned substances
- 20.2 Results
- 20.2.1 Milk results
- 20.2.1.1 Antimicrobials
- 20.2.1.2 Avermectins
- 20.3 EU relations
- CHAPTER 21 CANADA
- 21.1 Legislation and Regulation
- CHAPTER 22 UNITED STATES
- 22.1 Legislation and Regulation
- 22.2 National residue monitoring
- 22.2.1 Domestic sampling
- 22.2.2 Testing results
- 22.2.2.1 Monitoring sampling results
- 22.2.2.2 Enforcement results
- 22.2.3 Import sampling
- 22.2.4 Non-compliance
- CHAPTER 23 HORIZON ISSUES
- 23.1 Geographical and knowledge divide
- 23.1.1 Capacity building in developing countries
- 23.2 Technical considerations
- 23.2.1 Injection site residues
- 23.2.2 Residue depletion
- 23.2.3 Genotoxic and carcinogenic substances
- 23.2.4 Development of new techniques
- REFERENCES
About this Product
Delivery Details
PDF:Immediate delivery
PRINT/CD-ROM:
Related Products
Recently Viewed Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















